Ardelyx(ARDX)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

ARDX Ardelyx

交易中 01-13 14:09:29 EST

6.99

-0.37

-5.10%

最高7.34	最低6.93	成交量359.99万
今开7.31	昨收7.36	日振幅5.57%
总市值16.97亿	流通市值16.24亿	总股本2.43亿
成交额2,545万	换手率1.55%	流通股本2.33亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"ARDX","market":"US","secType":"STK","nameCN":"Ardelyx","latestPrice":6.985,"timestamp":1768331366171,"preClose":7.36,"halted":0,"volume":3599921,"delay":0,"floatShares":232528740,"shares":242974306,"eps":-0.236133,"marketStatus":"交易中","change":-0.375,"latestTime":"01-13 14:09:29 EST","open":7.31,"high":7.34,"low":6.93,"amount":25449596.870479602,"amplitude":0.055707,"askPrice":6.99,"askSize":841,"bidPrice":6.98,"bidSize":500,"shortable":3,"etf":0,"ttmEps":-0.236133,"tradingStatus":2,"nextMarketStatus":{"tag":"盘后交易","tradingStatus":3,"beginTime":1768338000000},"marketStatusCode":2,"adr":0,"adrRate":0,"listingDate":1403150400000,"exchange":"NASDAQ","adjPreClose":7.36,"preHourTrading":{"tag":"盘前","latestPrice":7.38,"preClose":7.36,"latestTime":"09:28 EST","volume":40605,"amount":298495.63842,"timestamp":1768314483090},"postHourTrading":{"tag":"盘后","latestPrice":7.3644,"preClose":7.36,"latestTime":"19:57 EST","volume":46095,"amount":339933.7294,"timestamp":1768265859822},"volumeRatio":0.473396,"impliedVol":0.6233,"impliedVolPercentile":0.4422},"requestUrl":"/m/hq/s/ARDX","defaultTab":"news","newsList":[{"id":"2584990254","title":"Ardelyx, Inc.盘中异动 股价大跌5.15%","url":"https://stock-news.laohu8.com/highlight/detail?id=2584990254","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2584990254?lang=zh_cn&edition=full","pubTime":"2025-11-20 00:49","pubTimestamp":1763570954,"startTime":"0","endTime":"0","summary":"北京时间2025年11月20日00时49分，Ardelyx, Inc.股票出现异动，股价大幅下跌5.15%。截至发稿，该股报5.51美元/股，成交量89.3736万股，换手率0.37%，振幅5.59%。Ardelyx, Inc.股票所在的生物技术行业中，整体跌幅为1.02%。Ardelyx, Inc.公司简介：Ardelyx Inc是一家生物制药公司，致力于开发和商业化同类首创的药品，以满足未被满足的医疗需求。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251120004914a704ce74&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251120004914a704ce74&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ARDX","BK4139"],"gpt_icon":0},{"id":"2581851742","title":"Ardelyx, Inc.2025财年第三财季实现净利润-969000.00美元，同比减少19.78%","url":"https://stock-news.laohu8.com/highlight/detail?id=2581851742","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2581851742?lang=zh_cn&edition=full","pubTime":"2025-11-08 00:01","pubTimestamp":1762531277,"startTime":"0","endTime":"0","summary":"11月8日，Ardelyx, Inc.公布财报，公告显示公司2025财年第三财季净利润为-969000.00美元，同比减少19.78%；其中营业收入为1.10亿美元，同比增加11.97%，每股基本收益为0.00美元。从资产负债表来看，Ardelyx, Inc.总负债3.32亿美元，其中短期债务1.44百万美元，资产负债比为1.47，流动比率为0.05。机构评级：截至2025年11月8日，当前有11家机构对Ardelyx, Inc.目标价做出预测，其中目标均价为11.82美元，其中最低目标价为8.00美元，最高目标价为16.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251108000200a490b854&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251108000200a490b854&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ARDX"],"gpt_icon":0},{"id":"2558950294","title":"Ardelyx, Inc.2025财年第二财季实现净利润-19.08百万美元，同比减少15.99%","url":"https://stock-news.laohu8.com/highlight/detail?id=2558950294","media":"市场透视","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2558950294?lang=zh_cn&edition=full","pubTime":"2025-08-10 00:01","pubTimestamp":1754755300,"startTime":"0","endTime":"0","summary":"8月10日，Ardelyx, Inc.公布财报，公告显示公司2025财年第二财季净利润为-19.08百万美元，同比减少15.99%；其中营业收入为97.66百万美元，同比增加33.38%，每股基本收益为-0.08美元。从资产负债表来看，Ardelyx, Inc.总负债3.27亿美元，其中短期债务1.18百万美元，资产负债比为1.43，流动比率为0.05。机构评级：截至2025年8月10日，当前有11家机构对Ardelyx, Inc.目标价做出预测，其中目标均价为11.18美元，其中最低目标价为8.00美元，最高目标价为15.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250810000350a47efc6d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250810000350a47efc6d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ARDX"],"gpt_icon":0},{"id":"1157046623","title":"异动解读 | 业绩超预期，Ardelyx盘中大涨17.08%","url":"https://stock-news.laohu8.com/highlight/detail?id=1157046623","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1157046623?lang=zh_cn&edition=full","pubTime":"2025-08-05 21:50","pubTimestamp":1754401839,"startTime":"0","endTime":"0","summary":"生物制药公司Ardelyx今日盘中股价大涨17.08%，延续了昨日盘后和今日盘前的强劲涨势。这一显著涨幅主要源于公司发布的2025年第二季度财报优于市场预期。根据Ardelyx公布的财报，公司第二季度调整后每股亏损为0.08美元，明显好于分析师平均预期的0.13美元亏损。值得注意的是，尽管Ardelyx在本季度表现出色，但公司今年以来的股价仍有所下跌。目前，分析师对Ardelyx的平均评级为\"买入\"，12个月目标价中位数为10.00美元，较最新交易价格仍有较大上涨空间。","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["ARDX"],"gpt_icon":0},{"id":"2557392625","title":"Ardelyx, Inc.盘中异动 大幅拉升17.61%","url":"https://stock-news.laohu8.com/highlight/detail?id=2557392625","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2557392625?lang=zh_cn&edition=full","pubTime":"2025-08-05 21:31","pubTimestamp":1754400677,"startTime":"0","endTime":"0","summary":"北京时间2025年08月05日21时31分，Ardelyx, Inc.股票出现波动，股价快速上涨17.61%。Ardelyx, Inc.股票所在的生物技术行业中，整体跌幅为2.54%。其相关个股中，Y-Mabs Therapeutics, Inc.、Shattuck Labs, Inc.、Adaptimmune Therapeutics Plc涨幅较大，Shattuck Labs, Inc.、Adaptimmune Therapeutics Plc、Cyclacel Pharmaceuticals, Inc.较为活跃，换手率分别为99.72%、74.49%、61.21%，振幅较大的相关个股有Plus Therapeutics, Inc.、Cellectis Ads Each Repr 1 Ord Spon、Adaptimmune Therapeutics Plc，振幅分别为10.82%、10.60%、8.70%。Ardelyx, Inc.公司简介：Ardelyx Inc是一家生物制药公司，致力于开发和商业化同类首创的药品，以满足未被满足的医疗需求。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250805213117a6d49d1a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250805213117a6d49d1a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ARDX","BK4139"],"gpt_icon":0},{"id":"2557666963","title":"二季度财报公布后阿德利克斯（Ardelyx）股价在盘前上涨12.1%。","url":"https://stock-news.laohu8.com/highlight/detail?id=2557666963","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2557666963?lang=zh_cn&edition=full","pubTime":"2025-08-05 16:17","pubTimestamp":1754381858,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK4139","ARDX"],"gpt_icon":0},{"id":"1188953367","title":"异动解读 | 业绩超预期，Ardelyx盘前大涨12.98%","url":"https://stock-news.laohu8.com/highlight/detail?id=1188953367","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1188953367?lang=zh_cn&edition=full","pubTime":"2025-08-05 16:05","pubTimestamp":1754381103,"startTime":"0","endTime":"0","summary":"生物制药公司Ardelyx今日盘前股价大涨12.98%，延续了昨日盘后的强劲涨势。这一显著涨幅主要源于公司发布的2025年第二季度财报优于市场预期。根据Ardelyx公布的财报，公司第二季度调整后每股亏损为0.08美元，明显好于分析师平均预期的0.13美元亏损。值得注意的是，尽管Ardelyx在本季度表现出色，但公司今年以来的股价仍下跌了14.6%。目前，分析师对Ardelyx的平均评级为\"买入\"，12个月目标价中位数为10.00美元，较最新收盘价4.33美元有约56.7%的上涨空间。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["ARDX"],"gpt_icon":0},{"id":"1162301018","title":"异动解读 | 业绩超预期，Ardelyx夜盘大涨7.29%","url":"https://stock-news.laohu8.com/highlight/detail?id=1162301018","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1162301018?lang=zh_cn&edition=full","pubTime":"2025-08-05 14:38","pubTimestamp":1754375915,"startTime":"0","endTime":"0","summary":"生物制药公司Ardelyx在夜盘交易中股价大涨7.29%，主要受益于公司发布的2025年第二季度财报优于市场预期。公司季度营收达到9766万美元，同比增长33.4%，同样超过了市场预期的8108万美元。这一亮眼的业绩表现引发了投资者的积极反应，推动股价在夜盘交易中大幅上涨。值得注意的是，尽管Ardelyx在本季度表现出色，但公司今年以来的股价仍下跌了14.6%。目前，分析师对Ardelyx的平均评级为\"买入\"，12个月目标价中位数为10.00美元，较最新收盘价4.33美元有约56.7%的上涨空间。","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["ARDX"],"gpt_icon":0},{"id":"1129708544","title":"异动解读 | 业绩超预期，Ardelyx股价盘后大涨15.03%","url":"https://stock-news.laohu8.com/highlight/detail?id=1129708544","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1129708544?lang=zh_cn&edition=full","pubTime":"2025-08-05 05:24","pubTimestamp":1754342679,"startTime":"0","endTime":"0","summary":"生物制药公司Ardelyx周一盘后股价大涨15.03%，主要受益于公司发布的2025年第二季度财报优于市场预期。公司季度营收达到9766万美元，同比增长33.4%，同样超过了市场预期的8108万美元。这一亮眼的业绩表现引发了投资者的积极反应，推动股价在盘后交易中大幅上涨。值得注意的是，尽管Ardelyx在本季度表现出色，但公司今年以来的股价仍下跌了14.6%。目前，分析师对Ardelyx的平均评级为\"买入\"，12个月目标价中位数为10.00美元，较最新收盘价4.33美元有约56.7%的上涨空间。","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["ARDX"],"gpt_icon":0},{"id":"2555123025","title":"Ardelyx, Inc.盘中异动 股价大涨5.09%","url":"https://stock-news.laohu8.com/highlight/detail?id=2555123025","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2555123025?lang=zh_cn&edition=full","pubTime":"2025-07-31 00:50","pubTimestamp":1753894249,"startTime":"0","endTime":"0","summary":"北京时间2025年07月31日00时50分，Ardelyx, Inc.股票出现波动，股价急速上涨5.09%。截至发稿，该股报4.44美元/股，成交量130.914万股，换手率0.55%，振幅3.55%。Ardelyx, Inc.股票所在的生物技术行业中，整体涨幅为0.77%。Ardelyx, Inc.公司简介：Ardelyx Inc是一家生物制药公司，致力于开发和商业化同类首创的药品，以满足未被满足的医疗需求。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025073100504994c44492&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025073100504994c44492&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ARDX"],"gpt_icon":0},{"id":"2551138455","title":"Ardelyx, Inc.盘中异动 下午盘股价大涨5.01%","url":"https://stock-news.laohu8.com/highlight/detail?id=2551138455","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2551138455?lang=zh_cn&edition=full","pubTime":"2025-07-15 01:35","pubTimestamp":1752514541,"startTime":"0","endTime":"0","summary":"北京时间2025年07月15日01时35分，Ardelyx, Inc.股票出现异动，股价快速拉升5.01%。Ardelyx, Inc.股票所在的生物技术行业中，整体涨幅为0.71%。其相关个股中，Sonnet Biotherapeutics Holdings, Inc.、Dare Bioscience, Inc.、Promis Neurosciences Inc.涨幅较大，Windtree Therapeutics, Inc.、Sonnet Biotherapeutics Holdings, Inc.、Dare Bioscience, Inc.较为活跃，换手率分别为2079.73%、1272.00%、721.43%，振幅较大的相关个股有Sonnet Biotherapeutics Holdings, Inc.、Promis Neurosciences Inc.、Dare Bioscience, Inc.，振幅分别为217.02%、210.04%、206.36%。Ardelyx, Inc.公司简介：Ardelyx Inc是一家生物制药公司，致力于开发和商业化同类首创的药品，以满足未被满足的医疗需求。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250715013541a6a94431&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250715013541a6a94431&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ARDX","BK4139"],"gpt_icon":0},{"id":"2517678444","title":"Ardelyx(ARDX.US)获Scotiabank首次覆盖，给予跑赢大盘评级, 目标价15.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2517678444","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2517678444?lang=zh_cn&edition=full","pubTime":"2025-03-08 06:32","pubTimestamp":1741386747,"startTime":"0","endTime":"0","summary":"Ardelyx(ARDX.US)获Scotiabank首次覆盖，给予跑赢大盘评级, 目标价15.00美元。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/03/08063248605335.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["ARDX"],"gpt_icon":0},{"id":"2516680663","title":"Ardelyx, Inc.盘中异动 临近收盘股价大跌5.04%","url":"https://stock-news.laohu8.com/highlight/detail?id=2516680663","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2516680663?lang=zh_cn&edition=full","pubTime":"2025-03-04 04:33","pubTimestamp":1741033982,"startTime":"0","endTime":"0","summary":"北京时间2025年03月04日04时33分，Ardelyx, Inc.股票出现异动，股价大幅下跌5.04%。Ardelyx, Inc.股票所在的生物技术行业中，整体跌幅为0.12%。其相关个股中，Bioxcel Therapeutics, Inc.、Abpro Holdings Inc C/Wts 12/11/2029 、Celularity Inc C/Wts 16/07/2026 涨幅较大，Bioxcel Therapeutics, Inc.、Allarity Therapeutics, Inc.、Entero Therapeutics Inc.较为活跃，换手率分别为4621.88%、215.19%、187.27%，振幅较大的相关个股有Bioxcel Therapeutics, Inc.、Radiopharm Theranostics Limited、Entero Therapeutics Inc.，振幅分别为206.20%、119.50%、70.53%。Ardelyx, Inc.公司简介：Ardelyx Inc是一家生物技术公司，致力于发现、开发和商业化创新的一流药物，以满足重大的未满足的医疗需求。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250304043302abe69753&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250304043302abe69753&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ARDX"],"gpt_icon":0},{"id":"2514386947","title":"Ardelyx, Inc.盘中异动 早盘股价大涨5.00%","url":"https://stock-news.laohu8.com/highlight/detail?id=2514386947","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514386947?lang=zh_cn&edition=full","pubTime":"2025-02-27 22:35","pubTimestamp":1740666917,"startTime":"0","endTime":"0","summary":"北京时间2025年02月27日22时35分，Ardelyx, Inc.股票出现异动，股价急速拉升5.00%。截至发稿，该股报5.36美元/股，成交量15.2529万股，换手率0.06%，振幅2.06%。Ardelyx, Inc.股票所在的生物技术行业中，整体涨幅为0.45%。Ardelyx, Inc.公司简介：Ardelyx Inc是一家生物技术公司，致力于发现、开发和商业化创新的一流药物，以满足重大的未满足的医疗需求。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250227223517989510af&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250227223517989510af&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ARDX"],"gpt_icon":0},{"id":"2513756039","title":"Ardelyx, Inc.2024财年实现净利润-39.14百万美元，同比增加40.76%","url":"https://stock-news.laohu8.com/highlight/detail?id=2513756039","media":"市场透视","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2513756039?lang=zh_cn&edition=full","pubTime":"2025-02-24 00:00","pubTimestamp":1740326452,"startTime":"0","endTime":"0","summary":"2月24日，Ardelyx, Inc.公布财报，公告显示公司2024财年净利润为-39.14百万美元，同比增加40.76%；其中营业收入为3.34亿美元，同比增加169.35%，每股基本收益为-0.17美元。从资产负债表来看，Ardelyx, Inc.总负债2.62亿美元，其中短期债务1.56百万美元，资产负债比为1.67，流动比率为0.05。机构评级：截至2025年2月24日，当前有8家机构对Ardelyx, Inc.目标价做出预测，其中目标均价为10.06美元，其中最低目标价为5.50美元，最高目标价为13.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250224000120a250ce05&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250224000120a250ce05&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ARDX"],"gpt_icon":0},{"id":"2513162291","title":"Ardelyx, Inc.盘中异动 早盘急速跳水5.24%","url":"https://stock-news.laohu8.com/highlight/detail?id=2513162291","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2513162291?lang=zh_cn&edition=full","pubTime":"2025-02-21 22:55","pubTimestamp":1740149749,"startTime":"0","endTime":"0","summary":"北京时间2025年02月21日22时55分，Ardelyx, Inc.股票出现波动，股价快速下跌5.24%。Ardelyx, Inc.股票所在的生物技术行业中，整体涨幅为0.28%。其相关个股中，Osr Holdings Inc C/Wts 09/02/2028 、Nkgen Biotech, Inc.、Omega Therapeutics, Inc.涨幅较大，Nkgen Biotech, Inc.、Aditxt, Inc.、Windtree Therapeutics, Inc.较为活跃，换手率分别为100.87%、88.38%、45.79%，振幅较大的相关个股有Osr Holdings Inc C/Wts 09/02/2028 、Omega Therapeutics, Inc.、Lexaria Bioscience Corp C/Wts 14/01/2026 ，振幅分别为57.50%、35.45%、33.83%。Ardelyx, Inc.公司简介：Ardelyx Inc是一家生物技术公司，致力于发现、开发和商业化创新的一流药物，以满足重大的未满足的医疗需求。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250221225549962b8133&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250221225549962b8133&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ARDX","BK4139"],"gpt_icon":0},{"id":"1126178599","title":"异动解读 | Ardelyx财报亮眼超预期 盘前股价大涨6.92%","url":"https://stock-news.laohu8.com/highlight/detail?id=1126178599","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1126178599?lang=zh_cn&edition=full","pubTime":"2025-02-20 20:40","pubTimestamp":1740055221,"startTime":"0","endTime":"0","summary":"Ardelyx是一家生物制药公司,主要专注于肾脏和心血管疾病等领域的药物开发。在周四盘前交易中,该公司股价大涨6.92%,引发市场广泛关注。公司此前公布的2024年第四季度财报数据超出市场预期,营收和盈利双双创下新高,这是导致股价强劲表现的主因。财报数据表现亮眼,充分反映了公司业务的快速发展和盈利能力提升。投资者对Ardelyx未来的持续增长前景更加看好,因此在盘前活跃买盘涌入,推动股价大涨。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["ARDX"],"gpt_icon":0},{"id":"1162116073","title":"Ardelyx第四季度2024年GAAP每股收益$0.02超出预期$0.01，销售额$1.1613亿超出预期$1.0994亿","url":"https://stock-news.laohu8.com/highlight/detail?id=1162116073","media":"财报速递","labels":["express"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1162116073?lang=zh_cn&edition=full","pubTime":"2025-02-20 20:38","pubTimestamp":1740055135,"startTime":"0","endTime":"0","summary":"Ardelyx报告季度每股收益为$0.02，超出分析师预期的$0.01，增长100％。相比去年同期每股盈利的亏损$，增加了116.67％。以上内容来自Benzinga Earnings专栏，原文如下：$Ardelyx$  reported quarterly earnings of $0.02 per share which beat the analyst consensus estimate of $0.01 by 100 percent. This is a 116.67 percent increase over losses of $ per share from the same period last year.  The company reported quarterly sales of $116.13 million which beat the analyst consensus estimate of $109.94 million by 5.63 percent.  This is a 237.95 percent increase over sales o","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Ardelyx第四季度2024年GAAP每股收益$0.02超出预期$0.01，销售额$1.1613亿超出预期$1.0994亿","news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ARDX"],"gpt_icon":0},{"id":"2512653661","title":"Ardelyx, Inc.盘中异动 早盘股价大涨5.01%报6.08美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2512653661","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2512653661?lang=zh_cn&edition=full","pubTime":"2025-02-18 22:38","pubTimestamp":1739889528,"startTime":"0","endTime":"0","summary":"北京时间2025年02月18日22时38分，Ardelyx, Inc.股票出现异动，股价快速拉升5.01%。截至发稿，该股报6.08美元/股，成交量23.3018万股，换手率0.10%，振幅4.49%。Ardelyx, Inc.股票所在的生物技术行业中，整体涨幅为0.27%。Ardelyx, Inc.公司简介：Ardelyx Inc是一家生物技术公司，致力于发现、开发和商业化创新的一流药物，以满足重大的未满足的医疗需求。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502182238499889fe6c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502182238499889fe6c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ARDX"],"gpt_icon":0},{"id":"2506305954","title":"Ardelyx, Inc.盘中异动 早盘股价大涨5.07%报5.80美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2506305954","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2506305954?lang=zh_cn&edition=full","pubTime":"2025-01-27 22:46","pubTimestamp":1737989194,"startTime":"0","endTime":"0","summary":"北京时间2025年01月27日22时46分，Ardelyx, Inc.股票出现波动，股价急速拉升5.07%。截至发稿，该股报5.80美元/股，成交量34.5643万股，换手率0.15%，振幅5.07%。Ardelyx, Inc.股票所在的生物技术行业中，整体涨幅为1.21%。Ardelyx, Inc.公司简介：Ardelyx Inc是一家生物技术公司，致力于发现、开发和商业化创新的一流药物，以满足重大的未满足的医疗需求。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202501272246359874b232&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202501272246359874b232&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ARDX","BK4139"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.ardelyx.com","stockEarnings":[{"period":"1week","weight":0.2085},{"period":"1month","weight":0.1852},{"period":"3month","weight":0.4691},{"period":"6month","weight":0.6},{"period":"1year","weight":0.4517},{"period":"ytd","weight":0.2624}],"compareEarnings":[{"period":"1week","weight":0.0108},{"period":"1month","weight":0.0197},{"period":"3month","weight":0.0497},{"period":"6month","weight":0.1136},{"period":"1year","weight":0.1975},{"period":"ytd","weight":0.0194}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Ardelyx, Inc.是一个临床阶段的生物制药公司，致力于发现，商用化的创新发展，非系统化的小分子药物治疗工作，专门在胃肠道方面，治疗心肾，胃肠和代谢性疾病。公司开发的药物发现和设计平台使它，在一个快速和成本有效的方式，去发现和设计新的候选药物。公司于2007年10月17日在特拉华成立，公司于2008年6月由nteryx更名为ardelyx。","yearOnYearQuotes":[{"month":1,"riseRate":0.666667,"avgChangeRate":0.051732},{"month":2,"riseRate":0.272727,"avgChangeRate":-0.033317},{"month":3,"riseRate":0.272727,"avgChangeRate":0.009259},{"month":4,"riseRate":0.545455,"avgChangeRate":0.001529},{"month":5,"riseRate":0.363636,"avgChangeRate":-0.132359},{"month":6,"riseRate":0.545455,"avgChangeRate":0.043647},{"month":7,"riseRate":0.583333,"avgChangeRate":-0.033676},{"month":8,"riseRate":0.666667,"avgChangeRate":0.106042},{"month":9,"riseRate":0.5,"avgChangeRate":0.057062},{"month":10,"riseRate":0.333333,"avgChangeRate":0.013627},{"month":11,"riseRate":0.666667,"avgChangeRate":0.143555},{"month":12,"riseRate":0.416667,"avgChangeRate":0.014591}],"exchange":"NASDAQ","name":"Ardelyx","nameEN":"Ardelyx"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.36.0","shortVersion":"4.36.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Ardelyx(ARDX)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Ardelyx(ARDX)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Ardelyx,ARDX,Ardelyx股票,Ardelyx股票老虎,Ardelyx股票老虎国际,Ardelyx行情,Ardelyx股票行情,Ardelyx股价,Ardelyx股市,Ardelyx股票价格,Ardelyx股票交易,Ardelyx股票购买,Ardelyx股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Ardelyx(ARDX)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Ardelyx(ARDX)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}